A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation
Information source: Ministry of Science and Technology of the People´s Republic of China
Information obtained from ClinicalTrials.gov on October 19, 2009 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Constipation
Intervention: Deep needle on ST25 (bilateral) with electric stimulator (Device); Lactulose (Drug); Huatuo brand needle, LH202H electric stimulator (Device)
Phase: Phase 3
Status: Recruiting
Sponsored by: Ministry of Science and Technology of the People´s Republic of China Official(s) and/or principal investigator(s): Zhishun Liu, M.D., Study Director, Affiliation: Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences
Overall contact: Zhishun Liu, M.D., Phone: 8610-010-88001124, Email: liuzhishun@yahoo.com.cn
Summary
The purpose of this study is to re-evaluate the therapeutic superiority and safety of
acupuncture treatment using high quality and large sampled clinical research. Our objectives
are to normalize the syndrome differentiation, point selection, technical procedure, and
electric acupuncture parameters, which provide high level evidence-based proofs for
acupuncture clinical treatments. We want to provide a preferred treatment protocol, which is
effective, safe, and easy to use in clinical practice. This research also clarifies that the
insertion depth is a key factor in the therapeutic effect of acupuncture. The results of our
study will help promote the development of the standardization of acupuncture.
Clinical Details
Official title: A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation
Study design: Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Number of complete spontaneous bowel movement (CSBM) per week
Secondary outcome: The number of subjects that had CSBM over 4 times per week,and self-evaluation on symptoms by patient
Detailed description:
Functional constipation is a high morbidity disease. The life-long treatment of functional
constipation can seriously impact a patient's quality of life. At present, the most
frequently used treatment is catharsis, which deals with the symptom. This therapy is
effective in the short-term for general functional constipation, whereas the effect is poor
in colonic slow transit constipation. There are three main problems with catharsis. First,
there are no long-lasting effects once the patient stops taking medication. Second, there
are many side effects, including abdominal pain with defecation and diarrhea. Third,
long-term use of irritant laxatives will not only make the constipation become refractory
and complex; but also, this type of medicine can harm the enteric nervous system, cause
melanosis coli, or even carcinoma of colon. Traditional Chinese Medicine diagnosis and
treatment has its own advantages in treating functional constipation, but the therapeutic
effect of treating colonic slow transit constipation is still uncertain. Although
constipation is relieved to a certain extent, the patient also suffers from abdominal pain
during defecation. Chinese herbs, such as Radix et Rhizoma Rhei, or Cassia angustifolia
Vahl, are laxatives which also provide short-term effects. Long-term administration of the
Chinese herbs will affect the regulation of Meissner's plexus, Auerbach's plexus, and
gastrointestinal hormones, as well as make the digestive system depend on laxatives.
Therefore, a therapy that is safe with minimal side effects and good short-term and
long-term effects is urgently needed in functional constipation treatment, especially for
the type of slow colonic transit functional constipation.
Clinical practice shows that acupuncture meets this need. The acupuncture therapy is safe
and effective especially for slow colonic transit functional constipation,and the
therapeutic effects are still present several months after the treatment has been completed.
Eligibility
Minimum age: 18 Years.
Maximum age: 75 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients are diagnosed by specialists in the department of anus and intestine,or the
department of gastroenterology according to the diagnostic criteria of functional
constipation.
- Age between 18 to 75 years old
- Conscious, favorable general condition, cooperate with examination and treatment
- Hemiplegic patients due to stroke should be able to take care of themselves (Barthel
Index≥50), and they can walk or use cane to walk 20m. And they are diagnosed as
functional constipation before stroke.
- Volunteer to join this research and sign the written informed consent prior to
receiving treatment
- Provide address and phone number, and cooperate with long-term follow-up
Exclusion Criteria:
- Irritable bowel syndrome, or constipation caused by tumor, inflammation, medication,
endocrine, or metabolic diseases
- Age younger than 18 years old, or older than 75 years old
- Known serious cardiovascular disease, hepatic injury, or renal damage; serious
cognitive dysfunction; aphasia, serious mental disorder; malnutrition, poor general
condition, unable to cooperate with examination or treatment
- Pregnancy or breast-feeding woman
- Abdominal aneurysm, abnormal splenohepatomegaly, enteroparalysis, partial intestinal
obstruction, celiac tuberculosis
- Coagulation disorders, or constantly use anticoagulant drugs, such as heparin
- Patients with cardiac pacemaker
- Patients who is seriously afraid of needles
- Patients who did not fill in constipation diary card in the baseline evaluation
period, or not volunteer to join this research program
- No contact method, unable to cooperate with follow-up
Locations and Contacts
Zhishun Liu, M.D., Phone: 8610-010-88001124, Email: liuzhishun@yahoo.com.cn
Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences, Beijing 100053, China; Recruiting Zhishun Liu, M.D., Phone: 8610-010-88001124, Email: liuzhishun@yahoo.com.cn Jinna Yu, M.D., Phone: 8610-010-88001413, Email: yujinnaa@sina.com Jinna Yu, M.D., Sub-Investigator
Additional Information
Starting date: April 2008
Ending date: December 2009
Last updated: September 17, 2009
|